Sponsor:
Johns Hopkins University
Code:
NCT07349758
Conditions
Healthy Volunteer
HIV Prevention
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
tenofovir alafenamide [TAF] 50 mg/emtricitabine [FTC] 400mg
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-14. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2026-01-20.